AI-generated summary
The authors summarize two decades of research on low-level light therapy, also called photobiomodulation, which uses red or near-infrared light. They review proposed biological mechanisms at the molecular, cellular and tissue levels. The abstract states that numerous clinical trials have shown biological efficacy, but that the underlying mechanisms are not yet fully explored.
- Who or what was studied
- unclear
- Wavelengths
- 600, 700, 780, 1100 nm
- Limits stated in the abstract
- The abstract does not describe the review method or number of studies, and states that the underlying mechanisms are not yet fully understood.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600-700 nm, 780-1100 nm
- Power density (irradiance)
- 5 mW/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Near-infrared, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.